drugset / Trial / NCT04293081
Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the study is to identify the role of preoperative chlorepheniramine maleate on alleviating or reducing the severity of postoperative agitation following FESS procedures.
Timeline
- Start
- 2019-01-16
- Primary completion
- 2019-05-31
- Completion
- 2019-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | chlorepheniramine maleate | Unknown | 45.5 mg | Intravenous |